ESC 365 - The effects of chronic cannabidiol dosing on cardiovascular parameters in primary hypertension: A summary of findings from a randomized controlled trial

ESC Professional Premium Access

The effects of chronic cannabidiol dosing on cardiovascular parameters in primary hypertension: A summary of findings from a randomized controlled trial

Session: New perspectives in cardiology (4) - Epidemiology and mechanisms of hypertension

Topic: Pathophysiology and Mechanisms

Speaker: Doctor M. Kumric (Split, HR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Marko Kumric

University of Split School of Medicine, Split (Croatia)

0 follower

8 more presentations in this session

Discussant - Epidemiology and mechanisms of hypertension

Impacts of RAS and renal perfusion on eGFR in hypertensive patients, independent of renal artery stenosis

Speaker: Doctor L. Zheng (Tianjin, CN)

Predictive capacity of events in hypertensive patients using artificial neural network analysis from ambulatory blood pressure monitoring data compared with clinical risk stratification

Speaker: Doctor M. Catalano (Buenos Aires, AR)

Apatinib treatment increases the expression of mitochondria-associated endoplasmic reticulum membranes proteins

Speaker: Doctor Y. Wang (Lanzhou, CN)

Blocking endoplasmic reticulum stress: attenuation of apatinib-induced hypertension in gastric cancer-bearing nude mice

Speaker: Doctor X. Ma (Lanzhou, CN)

Access the full session

New perspectives in cardiology (4) - Epidemiology and mechanisms of hypertension

Speakers: Doctor M. Kumric, Doctor L. Zheng, Doctor M. Catalano, Doctor Y. Wang, Doctor X. Ma

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources